Uterine natural killer (uNK) cells remarkably increase in number after implantation. NK cells or their precursors migrate from the blood stream and contribute to the increase. However, the contribution of uNK cells present in the virgin uterus has been unclear. To elucidate this issue, we examined uterine leukocyte subsets during pregnancy in BALB/c mice. The most dramatic change was the massive decrease in CD11b
INTRODUCTION
Natural killer (NK) cells are derived from common lymphoid progenitor cells in the bone marrow [1] . They are classically viewed as innate immune cells with important roles in host defense against tumor-transformed and virus-infected cells. More recently, NK cells have been found to share traits with the adaptive immune system, such as memory and dynamic trafficking [2, 3] . In addition to the fundamental role of NK cells in host defense, accumulating evidence strongly suggests an important role of NK cells during pregnancy [4, 5] .
Uterine NK (uNK) cells play key roles in the endometrial remodeling associated with pregnancy, including roles in the promotion of maternal angiogenesis and the transformation of the major maternal arterial branches supplying the placenta, called spiral arteries [6, 7] . It has been shown that mice deficient in NK cells display implantation site anomalies, incomplete uterine spiral artery remodeling, and impaired decidualization of uterine stromal cells [8] [9] [10] . Murine uNK cells produce a critical cytokine, interferon-gamma (IFN-c), to support pregnancy-associated vascularization of the uterus and the process of decidualization [11, 12] .
NK cells are present in the uterus both before and during gestation in mice and humans [13, 14] . Although the number of uNK cells is small before gestation, the number rapidly increases during decidualization in mice and peaks at Gestation Days (gds) 10 and 11, and the uNK cells begin to die shortly thereafter [15, 16] . It is thought that NK progenitor cells migrate mainly from the secondary lymphoid organs to the uterus, where they undergo further differentiation to constitute a major part of the uNK cells during early pregnancy [17] . However, it is still unclear whether uNK cells present in the uterus before gestation also proliferate and/or differentiate after gestation to contribute to the increase in uNK cell number. As an approach to this question, we used BALB/c mice to analyze leukocyte subsets, including uNK cells, in the uterus during pregnancy. We found a massive decrease in uNK cells at gd 6. Our interpretation of these results is that most of the uNK cells present in the uterus before gestation disappear during decidualization.
MATERIALS AND METHODS

Mice
Female BALB/c mice, some of which were virgins and others were pregnant at various gds, were obtained from Charles River Laboratories in Yokohama, Japan. Seven mice per cage were housed and maintained at the Toho University School of Medicine animal facility, according to institutional guidelines, under a 12L:12D cycle at 208C-228C in specific pathogen-free conditions. Food and water were available ad libitum. The mice were allowed an acclimation period of 2 wk and were used for the study at about 8 wk of age. The morning of copulation plug detection was designated as gd 1. Uteri were collected in the mornings of gd 4-12. The uterus was first cleaned of surrounding fat and blood vessels and then explanted by cutting just below the ovaries on each uterine horn and distal to the cervix. The uteri were carefully removed, excluding tissue from the trophoblast, developing fetus, or embryonic sac. The uterus of a nonpregnant female was isolated in a similar way, except that the whole uterine wall was processed. All the animal experiments were approved by the Institutional Review Board of the Toho University School of Medicine. cell suspensions. The red blood cells were removed using Tris-buffered ammonium chloride.
Reagents and Flow Cytometry
The following monoclonal antibodies were purchased from eBioscience (San Diego, CA): Allophycocyanin (APC)-or cyanine dye 5.5 (Cy5.5)-anti-CD45 (rat IgG2b [immunoglobulin G2b], j, 30-F-11); fluorescein isothiocyanate (FITC)-anti-CD3 (hamster IgG, 145-2C11); FITC-anti-CD27 (Armenian hamster IgG, LG3.7F9); FITC-anti-B220 (rat IgG2a, j, RA3-6B2); FITC-antiLy-6G (Gr1) (rat IgG2b, j, RB6-8C5); FITC-anti-CD11b (rat IgG2b, j, M1/ 70); phycoerythrin (PE)-anti-CD11c (Armenian hamster IgG, N418); FITCanti-CD14 (rat IgG2a, j, Sa2-8); FITC-or PE-anti-CD49b (rat IgM, j, DX5); FITC-anti-CD127 (IL-7R) (rat IgG2a, j, A7R34); and PE-anti-CXCR4 (rat IgG2b, j, 2B11B). FITC-anti-CXCL-12 (mouse IgG1, 79018), biotin-anti-IL-15 rabbit polyclonal antibody, and anti-IL-15 receptor alpha chain (IL-15Ra) (rat IgG2a, RM0103-6C38) were purchased from R&D Systems (Minneapolis, MN), Acris Antibodies (San Diego, CA), and Abcam (Cambridge, MA), respectively. Avidin-APC and FITC-anti-rat IgG rabbit polyclonal antibody were obtained from eBioscience and Beckman Coulter (Brea, CA), respectively. Anti-CD16/32 (rat IgG2b, j, 2.4G2, Becton Dickinson, San Diego, CA) was used to block Fc binding. Rat IgG, j was used as a control. Each antibody was used at an appropriate dilution which was determined under the experimental conditions according to the manufacturer's recommendation.
Antibodies were diluted appropriately in PBS containing 2% fetal calf serum (JRH Bioscience, Lenexa, KS). Cells were treated with anti-CD16/32 monoclonal antibody to block nonspecific antibody binding, resuspended in RPMI 1640 (Sigma-Aldrich, St. Louis, MO) containing 2% fetal calf serum, and stained serially with the indicated antibodies on ice for 30 min each. After washing carefully, treated cells were analyzed on the FACSCalibur (BD Biosciences, San Jose, CA) using CellQuest software (BD Biosciences) as described previously [18, 19] . Viable leukocytes were gated based on their forward scatter/side scatter profile. The percentages of positive cells and mean fluorescence intensity of positive cells were calculated.
For staining cells expressing intracellular IL-15, either CXCL-12 or IFN-c uterine cells were serially treated with FITC-anti-CD45 and APC-anti-CD49b at 48C for 30 min each, followed by treatment with 4% paraformaldehyde at room temperature for 15 min. After washing, the treated cells were incubated with an appropriate anti-cytokine antibody in the permeabilization buffer (PBS containing 1% saponin and 0.1% sodium azide) for 30 min. After washing, the cells were analyzed on a flow cytometer. For the detection of intracellular IFNc, uterine cells were stimulated in advance with 50 ng/ml phorbol 12-myristate 13-acetate and 100 ng/ml ionomycin in the presence of 10 lg/ml brefeldin A (Sigma-Aldrich) for 4 h.
Immunohistochemistry
Individual uteroplacental units were isolated from the uteri of mice at gd 0 or 12. One embryo was randomly selected and frozen. Frozen sections (4 lm) were prepared and pretreated serially both with 0.1% hydrogen peroxide for 10 min to inhibit endogenous peroxidase and with Block Ace (Dainippon Sumitomo Pharma, Osaka, Japan) to block nonspecific antibody binding. The treated sections were stained with biotin-anti-IL15 rabbit antibody and horseradish peroxidase-conjugated streptavidin, and developed with diaminobenzidine. Sections were counterstained with Mayer hematoxylin and analyzed under a light microscope.
Statistical Analysis
Statistical analysis of differences between numbers of cells on different days of pregnancy was performed using Student t-test. The data were obtained as percentages and expressed as means, with differences represented by 6 SD. A P value , 0.01 was considered to be statistically significant. All the experiments using flow cytometer were repeated at least three times.
RESULTS
Ratios of CD11b
À or Gr-1 À Cells in CD45 þ Cells in the Uterus Dramatically Decreased at gd 6
As an approach to analyzing changes in the leukocyte subsets in uterine cells during pregnancy, we first examined CD11b þ , CD11c þ , and Gr-1 þ cells in CD45 þ cells using BALB/c mice. The most dramatic finding was the remarkable decrease in the ratio of CD11b
À or Gr-1 À cells at gd 6 ( Fig.   1A ), which is the day the embryos implant and trigger the primary decidua response. The ratio recovered gradually and reached the gd 0 level at gd 12. The CD11c þ cells, which were only a few in number, did not change the ratio during the same observation period, gd 0-12. The ratio of CD11b
À cells in CD45 þ uterine cells during pregnancy was repotted. As shown in Figure 1B , the ratio of CD11b À or Gr-1 À cells, but not of CD11c À cells, severely decreased to an almost negligible level at gd 6. To confirm pregnancy, sections prepared from uteri at gd 6 were macroscopically and histologically examined. The presence of the embryos was observed (data not shown).
Gr-1 À cells consisted mostly of CD11b À , and vice versa (data not shown). Thus, we analyzed CD11b
À cells in the following experiments, where indicated.
CD49b
þ Uterine NK Cells Were Remarkably Decreased in Uterine CD45
þ Cells at gd 6
To analyze which subset of the uterine CD45 þ cells decreased at gd 6, the expression of cell surface markers on uterine CD45
þ cells at gd 6 was compared with those from the virgin mouse uteri. As shown in Figure 2A , the ratio of CD49b þ uNK cells among the CD45 þ cells in virgin uteri was about 35% but decreased dramatically to a very low level at gd 6. The ratio of CD3 þ , B220 þ , CD14 þ , or CD11c þ cells never decreased at gd 6 compared with each subset in virgin mouse uteri. Confirming the selective decrease in the ratio of CD49b þ cells, the histograms for CD49b þ cells obtained on a flow cytometer showed no positive peak among the CD45 þ uterine cells at gd 6, whereas a clear positive peak was observed in the CD49b þ cells from the virgin mice (Fig. 2B ). These CD49b þ cells were mostly CD3 À or B220 À (Fig. 2C ). In the virgin uteri, uNK cells with a few granules in the cytoplasm were consistently observed in CD11b À cells, but not in CD11b þ cells (data not shown).
The dramatic decrease in the number of CD49b þ uNK cells in uterine CD45
þ cells at gd 6 correlated with the severe decrease in the CD11b À cell ratio. As shown in Figure 3A , CD49b þ uNK cells in uterine CD45 þ cells from virgin mice were detected clearly in CD11b À cells, whereas they were negligible in CD11b þ cells. At gd 6, however, CD49b þ uNK cells in uterine CD45 þ cells were undetectable either in CD11b À or CD11b þ cells (Fig. 3B) . Not only the ratio, but also the absolute number of CD49b þ cells in CD45 þ cells was very small in the gd 6 uteri. As shown in Figure 4 , the total CD49b þ cell number in the uterine CD45 þ cells was quite small in the gd 6 mice compared with the virgin mice. Based on these findings, we concluded that murine CD49b þ uNK cells present in the virgin uteri selectively and dramatically decreased in number at gd 6.
Comparison of Uterine CD49b
þ Cells from Virgin Uteri and Uteri at gd 12
CD45
þ /CD11b À uterine cells were severely decreased at gd 6 but almost recovered to the virgin uterine level at gd 12 ( þ cells, and B220
cells in the virgin uteri were found at proportions of approximately 30%, 8%, and 20%, respectively, and at gd 12 at approximately 60%, 46%, and 48%, respectively. Thus, the CD27 þ , CD127 þ or B220 þ cells were present in a higher ratio in the uNK cells in the gd 12 uteri than in the virgin uteri. CD11b þ cells in uNK cells were few in number in the virgin uteri, as described above (Figs. 1, 2 , and 5A), but CD49b þ uNK cells consisted mostly of CD11b þ at gd 12 (Fig. 5B ). Taken together, these findings suggested that gd 12 uNK cells contained more mature subsets than those in the virgin uterus, as shown previously [20] [21] [22] [23] .
Uterine NK Cells at gd 12 Contained CXCR4 or IL-15 Receptor-Bearing Cells and IFN-c-Producing Cells After implantation, NK progenitor cells have been shown to migrate into the uterus and proliferate in response to IL-15 [24] . The interaction of CXCR4 on blood NK cells or their precursors with CXCL12 was shown to play a role in their migration into peripheral tissues and their activation [25, 26] . Under the experimental conditions of the present study, the high expression of CXCL12 was observed in CD45 À uterus cells from the virgin or gd 6 mice, whereas no detectable peak of the CXCL12 expression was obtained at gd 12 (Fig. 6 , left 
/CD49b
þ uNK cells expressed CXCR4 even in the virgin uteri, but the expression was somewhat higher at gd 12 (Fig. 6, right panel) .
Uterine CD45 À cells expressed IL-15 in virgin mice, but higher expression was observed at gd 12 (Fig. 7A) . The expression of IL-15 was histologically confirmed to be higher at gd 12 than in the virgin uteri (Fig. 7B) . The expression of IL-15 receptor alpha-chain (IL-15Ra) was observed on the cell surface of the CD45 þ /CD49b þ uNK cells at gd 12, whereas the expression was negligible on those from the virgin uteri ( Fig.   FIG. 2 . Uterine cells from virgin mice and gd 6 mice were prepared. A) The uterine cells were stained at first with anti-CD45-APC, and then with anti-CD3 À , anti-B220-, anti-CD49b-, anti-CD14-, or anti-CD11c-FITC. The percentages of CD3-, B220-, CD49b-, CD14-, or CD11c-bearing cells in CD45 þ cells are shown. **P , 0.01. B) The histograms for CD45 þ / CD49b þ cells from virgin uteri (thin line) and gd 6 uteri (bold line) were shown. Shaded area was obtained with a control antibody. C) The uterine cells were stained with anti-CD45-Cy5.5 and then with anti-CD3-or anti-B220-FITC. They were analyzed on a flow cytometer. These experiments were repeated more than three times, and averages 6 SD are shown in A.
Representative results are shown in B and C. TAKASHIMA ET AL. 7C). These findings strongly suggested that uNK cells at gd 12 expressed the IL-15 receptor, but the uNK cells in the virgin uteri did not. These findings were consistent with our interpretation that NK progenitor cells migrate into the uterus by the interaction of CXCR4 expressed on the surface of the progenitor cells, with CXCL12 being expressed on the uterine cells after gestation, and proliferate in response to IL-15 produced in the uterus.
Murine uNK cells support pregnancy-associated vascularization of the uterus and the process of decidualization through production of a critical cytokine, IFN-c [11, 12] . The murine CD45 þ /CD49b þ uNK cells were examined for their IFN-c expression in the experimental conditions produced by intracellular staining for cytokines. As shown in Figure 8 , the CD45 þ /CD49b þ uNK cells from the virgin mice evidently expressed IFN-c, and higher expression was observed at gd 12. These findings confirmed that murine CD45 þ /CD49b þ uNK cells produce IFN-c, which likely supports the vascularization and decidualization process.
DISCUSSION
The present study used a flow cytometer to analyze changes in the leukocyte subsets in the BALB/c mouse uterus during pregnancy. The most dramatic change was the massive decrease in the proportion of the CD11b À or Gr-1 À subset in the CD45 þ leukocytes in the uterus at gd 6, while the proportion of the CD11c À cells did not change under the conditions employed. The dramatic decrease of the CD11b À or Gr-1 À subset in the CD45 þ uterus leukocytes at gd 6 was repeatedly observed without exception in at least three independent series of experiments. In the CD45 þ leukocytes, CD49b þ uNK cells were mostly present in the CD11b À subset in the virgin uteri, but were almost undetectable in the CD11b
þ subpopulations at gd 6 during pregnancy. The decrease in the ratio and number of CD49b þ uNK cells was selectively observed because the ratios of the CD3 þ T cells,
þ leukocytes in the uteri were not decreased at gd 6 (Fig. 2) . The number of CD49b þ uNK cells in the virgin uteri was small, and further decreased severely at gd 6 (Fig. 4) . Thus, most of the uNK cells present in the virgin uteri seemed absent in the uteri by gd 6 when implantation was observed.
It is possible that uNK cells were not decreased at gd 6, but rather CD49b molecules disappeared on the surface of uNK cells as a result of trogocytosis. This possibility seems unlikely. CD49b þ cells at gd 6 were almost undetectable not only in
À uterus cells (data not shown). Uterus cells bearing NKp46, another NK cell marker, were also examined and found to be almost undetectable at gd 6 in either CD45 þ or CD45 -uterus cells (data not shown). Thus, evidence was not 
SEVERE DECREASE IN UTERINE NK CELL NUMBER AT GD 6
obtained supporting the trogocytosis of CD49b or NKp46 on uNK cells by other uterus cells. However, the possibility that trogocytosis is involved in the massive decrease in uNK cells at gd 6 cannot be formally ruled out. Further investigation will be required.
It is possible that the massively decreased number of uNK cells at gd 6 contained those derived from the uterus and those invading the uterus from secondary lymphoid organs during the decidualization process. Presently we have no evidence to discriminate between these two possibilities. However, the decrease at gd 6 seems mainly due to the decrease of uNK cells derived from the virgin uterus because the decidualization process is just beginning at gd 6.
There are only a few reports in which the uNK cell ratio or number at gd 6 have been described. In these reports, the ratio of uNK cells in the leukocytes at gd 5 or 6 never decreased compared with the virgin uterus [12, 16, 27, 28] , although Peel [29] described, based on histological findings, that granulated metrial grand cells, the former name of uNK cells, are virtually absent from the endometrium at the antimesometrial and lateral regions of the implantation site around at gd 6, but widely distributed in the mesometrial region. The reason for the difference between these results and the results of the present study is currently unknown. One possibility is that the mouse strains were different, and the time kinetics of the change in the uNK cell ratio or number during pregnancy might depend on the mouse strain. In the previous reports that described the ratio or number of uNK cells at gd 5 or 6, C57BL/6 or CD1 mice were employed [12, 16, 27, 28] , whereas the present study used BALB/c mice. Further investigations are required to elucidate the mechanisms for this discrepancy.
Regarding the considerable decrease of uNK cells at gd 6, at least two explanations are possible, cells going out of the uterus or in situ cell death in the uterus. The requirement of IL-15 for uNK cells to proliferate and survive, as reported previously [24, [30] [31] [32] , suggests the death of the uNK cells in the uterus because of insufficient IL-15 production and IL-15 receptor expression in the virgin uterus (Fig. 7) . Fas-FasL mechanisms might be included in the induction of uNK cell death as shown by the induction of apoptosis in uNK cells during late pregnancy in mice [33] . The mechanisms for the severe decrease in the uNK cell number at gd 6 remain to be elucidated.
It is now well-known that the number of uNK cells increases dramatically after implantation in the mouse uterus, peaks at gd 10-12, and decreases thereafter [5, 34] . The precursor cells of these uNK cells have been shown to be derived at least partly from secondary lymphoid tissues through the blood stream [17] . It is also possible that uNK cells in the virgin uterus partially contribute to the great increase after implantation. So far, it is not clear whether the uNK cells in the virgin mice, although only a few in number, contribute to the great increase of uNK cells during pregnancy. In the present study, uNK cells in the virgin uteri severely decreased at gd 6. Our interpretation is that these results did not support the possibility that they served as precursor cells for the increase of uNK cells at gd 9 or 12. However, we cannot formally rule out the possibility because uNK cells or their precursors have been shown to proliferate rigorously during pregnancy, and only five precursor cells have been postulated to totally generate the massive increase of uNK cells after implantation [29, 35] .
What is the biological significance for the decrease of uNK cell in number at gd 6? Although the significance is presently unknown, a possible explanation is that maternal NK cells, including uNK cells in the virgin uterus, are potentially cytotoxic against semiallogeneic fetal cells, including trophoblast cells. To avoid the potential cytotoxicity, uNK cells present in the virgin uterus might be dramatically decreased in number at gd 6. Then, noncytotoxic uNK cells or their progenitors might migrate into and differentiate in the pregnant uterus from secondary lymphoid organs during the decidualization process to support the pregnancy.
Bone marrow-derived NK cell precursors have been shown to migrate into the uterus [17] . The migration of NK cell precursors into the uterus is mediated through a chemokine, CXCL12, and chemokine receptor, CXCR4 [25, 36] . The results of the present study consistently demonstrated the expression of CXCL12 on the uterus CD45 À cells in the virgin or gd 6 uteri and the expression of CXCR4 on the uNK cells. Regarding the extensive proliferation and survival of uNK cells, IL-15 has been shown to play a critical role [24] . In the present study, IL-15 expression on the uterine CD45 À cells was higher at gd 12 than at gd 0, and the IL-15Ra on uNK cells was detected at gd 12, whereas was negligible in the virgin uterus. Thus, the results of the present study also support the previous interpretation that precursor NK cells migrate into the pregnant uterus and proliferate vigorously to constitute the main part of the considerable increase of the uNK cell number during pregnancy [5, 34] . The expression of CXCL12 on CD45 À cells at gd 12 was quite low (Fig. 6) , which suggested that it was difficult for NK cells or their precursors in the blood stream to migrate into the uterus at this stage, and was consistent with the decrease in uNK cell number after the peak at gd 10-12. In comparison with the cell surface phenotype of uNK cells at gd 12 with that in the virgin uteri, the ratio of the CD11b [20] [21] [22] [23] . In addition, B220
þ NK cells are shown to produce IFN-c [37] . The uNK cells at gd 12, but not those in the virgin uteri, consistently produced IFN-c (Fig. 8) . Thus, the results of the present study support the possibility that without the participation of the progeny of uNK cells in the virgin uterus, activation and maturation of uNK cells are induced during pregnancy to produce IFN-c, as summarized previously [38] .
In humans, uNK cells start to accumulate during menstruation before implantation [34] , indicating that uNK cells never decrease in number before implantation. The origin of CD56 bright CD16 À uNK cells that peak during the secretory phase of luteal cycle and early pregnancy is not established, and evidence indicates multiple different possibilities, such as CD56 bright CD16 À and CD56 dull CD16 þ peripheral blood NK cells [34] . It is also possible that uNK cells may derive from progenitors that constitutively reside in uterine tissue. By analogy with the results of the present study, the latter possibility might be unlikely. Progenitor cells constitutively resident in the virgin uterus might differentiate into cytotoxic NK cells to defend against virus infection in or malignant cell invasion into the uterus, as discussed previously [34] . To avoid the possible cytotoxicity against fetal cells, including trophoblast cells, they might almost disappear just before the start of the decidualization process. To elucidate this possibility, further investigation will be required.
